| MCRB |
Seres Therapeutics, Inc. |
15 Feb 2026 |
4 |
-$754 |
4 |
Chief Scientific Officer and EVP |
18 Feb 2026, 16:30 |
| MCRB |
Seres Therapeutics, Inc. |
15 Nov 2025 |
7 |
-$21,746 |
4 |
Chief Scientific Officer and EVP |
18 Nov 2025, 16:30 |
| MCRB |
Seres Therapeutics, Inc. |
26 Sep 2025 |
1 |
$0 |
4 |
Chief Scientific Officer and EVP |
30 Sep 2025, 16:30 |
| MCRB |
Seres Therapeutics, Inc. |
15 Aug 2025 |
5 |
-$1,215 |
4 |
Chief Scientific Officer and EVP |
19 Aug 2025, 16:07 |
| MCRB |
Seres Therapeutics, Inc. |
15 May 2025 |
5 |
-$561 |
4 |
Chief Scientific Officer and EVP |
19 May 2025, 16:05 |
| MCRB |
Seres Therapeutics, Inc. |
15 Feb 2025 |
5 |
-$3,204 |
4 |
Chief Scientific Officer and EVP |
19 Feb 2025, 20:10 |
| MCRB |
Seres Therapeutics, Inc. |
07 Feb 2025 |
1 |
$0 |
4 |
Chief Scientific Officer and EVP |
11 Feb 2025, 16:15 |
| MCRB |
Seres Therapeutics, Inc. |
15 Nov 2024 |
3 |
-$501 |
4 |
Chief Scientific Officer and EVP |
19 Nov 2024, 16:15 |
| MCRB |
Seres Therapeutics, Inc. |
27 Oct 2024 |
3 |
-$2,749 |
4 |
Chief Scientific Officer and EVP |
29 Oct 2024, 18:27 |
| MCRB |
Seres Therapeutics, Inc. |
15 Aug 2024 |
3 |
-$775 |
4 |
Chief Scientific Officer and EVP |
19 Aug 2024, 17:42 |
| MCRB |
Seres Therapeutics, Inc. |
15 May 2024 |
3 |
-$838 |
4 |
Chief Scientific Officer and EVP |
17 May 2024, 20:17 |
| MCRB |
Seres Therapeutics, Inc. |
14 Feb 2024 |
6 |
-$4,504 |
4 |
Chief Scientific Officer and EVP |
16 Feb 2024, 21:31 |
| MCRB |
Seres Therapeutics, Inc. |
27 Oct 2023 |
4 |
-$5,246 |
4 |
Chief Scientific Officer and EVP |
31 Oct 2023, 21:36 |
| MCRB |
Seres Therapeutics, Inc. |
27 Apr 2023 |
1 |
$0 |
4 |
Chief Scientific Officer and EVP |
01 May 2023, 16:41 |
| MCRB |
Seres Therapeutics, Inc. |
03 Feb 2023 |
2 |
$0 |
4 |
Chief Scientific Officer and EVP |
07 Feb 2023, 16:46 |
| MCRB |
Seres Therapeutics, Inc. |
08 Sep 2022 |
1 |
$0 |
4 |
Chief Scientific Officer and EVP |
09 Sep 2022, 16:46 |
| MCRB |
Seres Therapeutics, Inc. |
05 Jul 2022 |
1 |
+$150,000 |
4 |
Chief Scientific Officer and EVP |
06 Jul 2022, 19:27 |
| MCRB |
Seres Therapeutics, Inc. |
04 Feb 2022 |
1 |
$0 |
4 |
Chief Scientific Officer and EVP |
08 Feb 2022, 20:30 |